The Oxford-based medtech company OrganOx has developed a groundbreaking device that is changing the face of liver transplantation, with the technology hailed as a “game-changer” by industry experts. “More patients could now be offered a chance of a transplant, potentially extending their lives,” says Kevin Harris at the UK’s National Institute for Health and Care Excellence, which approved the device for use in January 2019.
In October 2018, BOOST&Co gave OrganOx a growth capital loan of £3m, to scale up and expand internationally. The firm’s metra device, which enable organs to be stored at normal body temperatures for extended periods of time, has now been used to complete more than 500 transplants in 11 countries, and the company’s revenues have increased by around 100% during the past 12 months.
Read our latest news and insights